Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis
Open Access
- 1 November 2016
- journal article
- Published by Elsevier BV
- Vol. 291 (46), 24160-24171
- https://doi.org/10.1074/jbc.m116.751974
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01GM105404, R01AR066101, R01AG048388)
This publication has 28 references indexed in Scilit:
- Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in OsteosarcomaCancer Research, 2009
- Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and DiseaseEndocrine Reviews, 2007
- X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solutionQuarterly Reviews of Biophysics, 2007
- Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor κB ligand (RANKL) and RANKBiochemical and Biophysical Research Communications, 2006
- Functional Dissection of Osteoprotegerin and Its Interaction with Receptor Activator of NF-κB LigandPublished by Elsevier BV ,2005
- An efficient one-step site-directed and site-saturation mutagenesis protocolNucleic Acids Research, 2004
- Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cellsBlood, 2002
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory FactorPublished by Elsevier BV ,1998
- An Animal Cell Mutant Defective in Heparan Sulfate Hexuronic Acid 2- -SulfationPublished by Elsevier BV ,1996